A month and a half ago, when Pfizer and Modern they had not yet announced the cuts in deliveries of vaccines for the first quarter and serum Astrazeneca seemed the way out of the emergency by the summer, Massimo Galli was clearly against the hypothesis of postponing i recalls of the anti-Covid drug. A practice not foreseen by the protocols of pharmaceutical companies but adopted by UK e Israel, both struggling with skyrocketing infections and returning from multiple national lockdowns. “It’s something we don’t have no information, out of any rule. You actually experienced one thing in one way and for emergency reasons you are giving it in another“, Said the virologist of the Sacco hospital in Milan a Cartabianca, on Rai3. His colleague from the University of Padua also agreed with him Andrea Crisanti. But now that vaccines are in short supply and there is a risk of “a wave sustained by variations“, Galli admits he has changed his mind. “The first scientific data from Israel and they say that after the first dose there was a collapse of infections all over the country. If the result is so vast and documented, we can think about it ”, explains a Ilfattoquotidiano.it. But he warns: “Gods are needed stakes, for example guarantee the second dose to the more fragile, avoid vaccinating those who have already had the disease, groped to make gods vaccination lockdowns in the most affected areas “.
Professor Galli, why are you now considering this hypothesis?
It costs me a lot of effort to change line while running, but there is one difference compared to a month and a half ago. While the British have chosen this strategy a priori, making an unsustainable speech, (‘If you are at war, you behave like one’), there is now a measurable result. Data from Israel (published, although not yet complete) confirm that there has been a collapse in infections after the first dose. I am not saying to do just one, but at least to discuss whether postpone it compared to the protocols currently envisaged (for Pfizer the recall must be made later 21 days, for Moderna after 28 and for Astrazeneca after 10-12 weeks, ed). In this way we would have more doses to administer immediately and there would be no need for set aside those for calls. However, precise conditions must be established.
Which?
First of all, you need to decide how to deal with fragile people. I would think twice not to make the call of Pfizer and Moderna to the immunodepressi or to those with serious illnesses. Then there are the over 80: According to Israeli data, they may even receive only one dose, but some extra caution is needed. The case is different Young people, there you could decide to give only one injection and postpone the second one.
To do it after how long?
The criterion might be to check the antibody titer in citizens. Who has an immune response 20 days after the first Pfizer dose, for example, he could skip the protocol appointment on the 21st day and do it later. We must evaluate and to monitor the antibody titer. And you could do the same with who he is already healed from Covid, so as to avoid injecting the vaccine and save doses for other people. I’ve been saying this for months, but they don’t listen to me about this.